In 2022, the global canine arthritis treatment industry size will have a net worth of US$ 2.39 billion. By 2028, the market for pharmaceuticals used to treat canine arthritis is expected to be worth US$ 3.05 billion, growing at a CAGR of 4.2%. Canine arthritis is a degenerative joint disease caused by frequent rubbing, cartilage …